RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing, Health Information Technology, and Essential Health Benefits. H.R. 3204 - Drug Quality and Security Act - issues addressing secure pharmaceutical supply chain and drug compounding practices.S. Con Res. 8 - Senate Budget Resolution for FY 2014 - Issues related to Medicare Part D H. R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act- focus on legislation that would negatively impact individuals access to mail order pharmacy. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes included in proposed OPM-focused policies in the Administration's 2014 Budget related to the utilization of Pharmacy Benefit Managers. TriCare and mail order issues. Policies related to stopping prescription medication diversion. Issues related to international naming policies for generic medications Issues related to the Medicare Call Letter which could impact mail order utilization in Medicare Part D ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Medicare/Medicaid MMM
Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs and related entities. Monitoring potential health-related offsets related to Medicare Part D, Exchange-based and Medicaid pharmacy benefits. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes.Working with CMS on Medicaid guidance specifically related to individual state pharmacy programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Pharmacy PHA
H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. H.R. 3204 - The Drug Quality and Security Act. Legislation to address secure the pharmaceutical supply chain and drug compounding practices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.